What's Happening?
Aidan Miller, a top infield prospect for the Philadelphia Phillies, has undergone a minimally invasive back procedure known as radiofrequency ablation of the facet joints. This surgery was deemed necessary due to persistent back pain and facet inflammation
in his lumbar spine, which has kept him from participating in any minor league games this season. Miller, who was the 27th overall pick in the 2023 draft, has seen his prospect ranking slip from 14th to 61st on Baseball America's top-100 list due to his injury and the emergence of other prospects. Despite his young age, Miller has already reached the Triple-A level, showcasing impressive stats in both Double-A and Triple-A last season. The Phillies hope the procedure will allow him to return to play in six to eight weeks.
Why It's Important?
Miller's recovery and return to form are crucial for the Phillies, who are looking to bolster their infield options. With current infielders like Alec Bohm and Bryson Stott underperforming, Miller's potential return could provide a much-needed boost. His ability to play multiple infield positions adds flexibility to the Phillies' roster management. Additionally, Miller's development is significant for the team's long-term planning, as he could fill potential gaps left by free agents or underperforming players. His progress will be closely monitored by the Phillies' management as they assess their future infield lineup.
What's Next?
If Miller's recovery goes as planned, he could be a candidate for a major league call-up later in the season. However, this is contingent on his performance upon returning to the field and the effectiveness of the surgery. The Phillies will likely keep him in the minors to maintain roster flexibility unless he forces a promotion with standout performances. His eligibility for the Rule 5 Draft in 2027 also plays a role in the team's decision-making regarding his roster status.
